Tarsus director granted RSUs and stock options
Tarsus Pharmaceuticals director Morrison Scott W received new equity awards tied to his service as a non-employee director.
Rhea-AI Filing Summary
Tarsus Pharmaceuticals director Morrison Scott W received new equity awards tied to his service as a non-employee director. He was granted 2,417 Restricted Stock Units, each representing a right to receive one share of common stock, and 3,837 stock options to buy common stock at an exercise price of $64.34 per share.
Both the RSUs and options were granted as of the company’s 2026 annual meeting of stockholders and will vest in full on the one-year anniversary of the grant date, subject to his continuous service. Following these grants, his reported holdings in these specific RSU and option awards are 2,417 and 3,837 units, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 6,254 shares
Grant/Award
2 txns
Insider
Morrison Scott W
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,837 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 2,417 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,837 contracts (Direct);
Restricted Stock Units — 2,417 contracts (Direct)
Footnotes (3)
- F1. Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- F2. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- F3. RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Key Figures
RSU grant size: 2,417 RSUs
Stock option grant size: 3,837 options
Option exercise price: $64.34 per share
+3 more
6 metrics
RSU grant size
2,417 RSUs
Granted June 25, 2026 for non-employee director service
Stock option grant size
3,837 options
Granted June 25, 2026 as annual director option
Option exercise price
$64.34 per share
Stock Option (right to buy) on Tarsus common stock
Option expiration date
June 24, 2036
Expiration for director stock option grant
RSUs underlying shares
2,417 shares common stock
Each RSU equals one share of common stock
Options underlying shares
3,837 shares common stock
Shares subject to stock option grant
Key Terms
Restricted Stock Units, Stock Option (right to buy), non-employee director, annual meeting of stockholders, +1 more
5 terms
Restricted Stock Units financial
"He was granted 2,417 Restricted Stock Units, each representing a right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"He was granted 3,837 stock options to buy common stock at an exercise price"
non-employee director financial
"granted in connection with the Reporting Person's service as a non-employee director"
annual meeting of stockholders financial
"granted in connection with the Company's 2026 annual meeting of stockholders"
vest in full financial
"The RSUs vest in full on the one-year anniversary of the date of grant"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Tarsus Pharmaceuticals (TARS) director Morrison Scott W receive in this Form 4?
He received two equity awards: 2,417 Restricted Stock Units and 3,837 stock options in Tarsus Pharmaceuticals. Both awards compensate his service as a non-employee director in connection with the company’s 2026 annual meeting of stockholders.
How do the Restricted Stock Units granted to the TARS director work?
Each RSU represents a contingent right to receive one share of Tarsus common stock. The 2,417 RSUs were granted for his non-employee director service and will vest in full one year after the grant date, assuming continuous service on the board.
What are the key terms of the stock options granted to the TARS director?
He was granted 3,837 stock options with an exercise price of $64.34 per share, expiring on June 24, 2036. The options were issued as an annual grant for board service and will vest fully one year after the grant date, subject to continuous service.
Are the equity awards to the TARS director open-market purchases or compensation grants?
They are compensation-related grants, not open-market trades. The Form 4 uses transaction code “A” for grant or award acquisitions, reflecting routine annual equity compensation for a non-employee director rather than discretionary buying or selling in the market.
When will the TARS director’s RSUs and stock options vest?
Both awards will vest in full on the one-year anniversary of the June 25, 2026 grant date. Vesting is conditioned on his continuous service as a non-employee director through that one-year period following the grant.
AI-generated analysis. How Rhea-AI works. Not financial advice.
